Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Trillium Therapeutics Inc.
T.TRIL
Healthcare
Biotechnology
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TRIL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
(3213)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Oct 26, 2021 5:26pm
Securityholders Approve Acquisition by Pfizer
CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing
...more
(340)
•••
nrv090909
X
View Profile
View Bullboard History
Comment by
nrv090909
on Aug 25, 2021 1:41pm
RE:Thanks for Therma Bright recommendation!
therma bright pending FDA approval, it will go sky high after, any day no wFDA approval. GLTA
Debt-Free and Thriving: Mining Company Reports 35% Revenue Growth in Q3 2024
posted Nov 12, 2024 9:00am by
Mandalay Resources Corp.
-
|
"Revenue growth and free cash flow generation reflect our cost controls and prudent capital management while benefitting from high metal prices. As of the end of Q3 our cash balance was a healthy $54.7 million – more than doubling since December 2023 – and we have fully repaid the $20 million outstanding balance on our revolving credit facility, strengthening our liquidity and financial flexibility ...read more
(8)
•••
HarleyD
X
View Profile
View Bullboard History
Post by
HarleyD
on Aug 25, 2021 7:54am
Thanks for Therma Bright recommendation!
Good day Everyone, This is my first post. I've registered, because I sold TRIL and am looking for another investment opportunity. Can you please suggest a few more firms for me? TIA! GLTA!
(93)
•••
birch1
X
View Profile
View Bullboard History
Comment by
birch1
on Aug 24, 2021 6:32pm
RE:Another acquisition…
lets hope about Therma Bright. in that one heavily. haven't posted on Stockhouse for TRIL because more activity in this regard on Stocktwitts. But good for everyone holding.
...more
(0)
•••
box532
X
View Profile
View Bullboard History
Comment by
box532
on Aug 24, 2021 1:52pm
RE:GREAT PUMP & DUMP
This post aged well.
(68)
•••
BUYSELL101
X
View Profile
View Bullboard History
Post by
BUYSELL101
on Aug 23, 2021 3:37pm
Another acquisition…
Therma bright and acuvid is next!
(77)
•••
crappot
X
View Profile
View Bullboard History
Comment by
crappot
on Aug 23, 2021 2:45pm
RE:RE:GREAT PUMP & DUMP
IN 5yrs LMNL will be Back To 3000, Pony Up!
(77)
•••
crappot
X
View Profile
View Bullboard History
Comment by
crappot
on Aug 23, 2021 2:34pm
RE:RE:GREAT PUMP & DUMP
Ya, A 5yr INVESTMENT YOU MADE 0%
(3)
•••
gcap1
X
View Profile
View Bullboard History
Post by
gcap1
on Aug 23, 2021 11:31am
investigation pending!
https://stockhouse.com/news/press-releases/2021/08/23/trillium-therapeutics-merger-investigation-halper-sadeh-llp-announces
(88)
•••
JWING17
X
View Profile
View Bullboard History
Comment by
JWING17
on Aug 23, 2021 10:06am
RE:GREAT PUMP & DUMP
LOOKS GOOD ON YOU....CRAPPOT....ANOTHER KNOW IT ALL.
(60)
•••
MomenTom
X
View Profile
View Bullboard History
Post by
MomenTom
on Aug 23, 2021 9:26am
Pfizer acquires Trillium 2.26 billion deal (18.50$ / share)
Aug 23 (Reuters) - Pfizer Inc said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc in a $2.26 billion deal to strengthen its arsenal of blood cancer therapies. Pfizer, which
...more
(2)
•••
Longtimecoming
X
View Profile
View Bullboard History
Comment by
Longtimecoming
on Aug 18, 2021 9:52pm
RE:I GOT FIRST STAGE CANCER BEATEN
yeahhhHHH! way to go!
(77)
•••
crappot
X
View Profile
View Bullboard History
Post by
crappot
on Jul 01, 2021 3:06pm
I GOT FIRST STAGE CANCER BEATEN
SEND ME 5M
(77)
•••
crappot
X
View Profile
View Bullboard History
Post by
crappot
on Jul 01, 2021 3:02pm
GREAT PUMP & DUMP
MUST BE CANADIAN....
(4)
•••
thesheet
X
View Profile
View Bullboard History
Comment by
thesheet
on May 11, 2021 8:25pm
RE:Trillium Therapeutics mentioned:
couldn't find any mention of trillium sorry
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet the Top 5 Best Online Brokerages in Canada
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips